ATE397673T1 - Verstärktes krebs-gen wip1 - Google Patents
Verstärktes krebs-gen wip1Info
- Publication number
- ATE397673T1 ATE397673T1 AT02723130T AT02723130T ATE397673T1 AT E397673 T1 ATE397673 T1 AT E397673T1 AT 02723130 T AT02723130 T AT 02723130T AT 02723130 T AT02723130 T AT 02723130T AT E397673 T1 ATE397673 T1 AT E397673T1
- Authority
- AT
- Austria
- Prior art keywords
- wip1
- cancer gene
- prevention
- enhanced cancer
- diagnosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26836201P | 2001-02-14 | 2001-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE397673T1 true ATE397673T1 (de) | 2008-06-15 |
Family
ID=23022645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02723130T ATE397673T1 (de) | 2001-02-14 | 2002-02-12 | Verstärktes krebs-gen wip1 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030032027A1 (de) |
EP (1) | EP1370693B1 (de) |
AT (1) | ATE397673T1 (de) |
CA (1) | CA2438420A1 (de) |
DE (1) | DE60226956D1 (de) |
WO (1) | WO2002064838A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003222058A1 (en) * | 2002-03-22 | 2003-10-13 | The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health | Materials and methods for inhibiting wip-1 |
AU2004249193A1 (en) * | 2003-06-20 | 2004-12-29 | Amgen Inc. | Gene amplification and overexpression in cancer |
US9040491B2 (en) * | 2006-08-30 | 2015-05-26 | The Trustees Of The University Of Pennsylvania | Compositions, methods and kits based on small nuclear RNAs |
US8740762B2 (en) * | 2007-04-05 | 2014-06-03 | Vanderbilt University | Specific inhibition of cPLA2 enhances the efficacy of radiotherapy |
US20100256098A1 (en) * | 2007-08-31 | 2010-10-07 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods |
GB201220924D0 (en) * | 2012-11-21 | 2013-01-02 | Cancer Res Inst Royal | Materials and methods for determining susceptibility or predisposition to cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5516663A (en) * | 1990-01-26 | 1996-05-14 | Abbott Laboratories | Ligase chain reaction with endonuclease IV correction and contamination control |
EP1068528B1 (de) * | 1998-02-25 | 2006-08-02 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Verfahren und vorrichtung zur erstellung eines arrays für schnelle molekulare profilidentifizierungen |
US6232068B1 (en) * | 1999-01-22 | 2001-05-15 | Rosetta Inpharmatics, Inc. | Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies |
-
2002
- 2002-02-12 AT AT02723130T patent/ATE397673T1/de not_active IP Right Cessation
- 2002-02-12 EP EP02723130A patent/EP1370693B1/de not_active Expired - Lifetime
- 2002-02-12 DE DE60226956T patent/DE60226956D1/de not_active Expired - Fee Related
- 2002-02-12 US US10/073,123 patent/US20030032027A1/en not_active Abandoned
- 2002-02-12 CA CA002438420A patent/CA2438420A1/en not_active Abandoned
- 2002-02-12 WO PCT/US2002/003991 patent/WO2002064838A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2438420A1 (en) | 2002-08-22 |
DE60226956D1 (de) | 2008-07-17 |
WO2002064838A2 (en) | 2002-08-22 |
US20030032027A1 (en) | 2003-02-13 |
EP1370693B1 (de) | 2008-06-04 |
WO2002064838A3 (en) | 2003-10-16 |
EP1370693A2 (de) | 2003-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008008315A3 (en) | Compositions and methods for inhibiting growth of smad4-deficient cancers | |
WO2003079982A3 (en) | Gene amplification in cancer | |
WO2002064839A3 (en) | Methods for the diagnosis and treatment of tumors employing the hepsin gene | |
WO2004070062A3 (en) | Compositions and methods for diagnosing and treating cancers | |
ATE538215T1 (de) | Expressionsprofil von prostatakarzinom | |
TR200102191T2 (tr) | HER-2/neu füzyon proteinleri. | |
WO2004046342A3 (en) | Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas | |
WO2004046332A3 (en) | Amplified genes involved in cancer | |
WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
WO2002071928A3 (en) | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer | |
WO2003000012A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
WO2003050243A3 (en) | Novel genes encoding colon cancer antigens | |
WO2004067570A3 (en) | Prostate cancer diagnosis and treatment | |
WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
WO2003100000A3 (en) | Amplification and overexpression of oncogenes | |
UA99602C2 (ru) | Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток | |
WO2003044161A3 (en) | Gene amplification and overexpression in cancer | |
WO2003064593A3 (en) | Antigen panels and methods of using the same | |
WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
EP1377596A4 (de) | Ttk in der diagnose und als therapeutisches target bei krebs | |
ATE397673T1 (de) | Verstärktes krebs-gen wip1 | |
WO2003054512A3 (en) | Identification of an amplified gene and target for drug intervention | |
IL207012A0 (en) | Diagnosis and therapy of cancer using sgp28-related molecules | |
ATE435224T1 (de) | Neue piperidinsubstituierte diaminothiazole | |
WO2003083102A3 (en) | Cancer associated protein phosphatases and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |